To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Renal Function and Renal Impairment.
Clinical trial NCT04831996 · COMPLETED
Trial details
- NCT number
- NCT04831996
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-04
- Primary completion
- 2022-07-08
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.